Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant oxaliplatin-capecitabine before CRS-HIPEC for colorectal peritoneal metastases
NL-OMON38114Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of oxaliplatin, capecitabine and mitomycin c in colorectal cancer (CRC) and peritoneal carcinomatosis (PC), sponsored by University Medical Center Groningen. Started Mar 2013; status: recruiting.
02
Drugs
oxaliplatincapecitabinemitomycin c
03
Conditions
colorectal cancer (CRC)peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NL-OMON38114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38114.